Nanoconjugates of poly(malic acid) with functional modules for drug delivery

J. Y. Ljubimova, M. Fujita, B. S. Lee, N. M. Khazenzon, Sebastian Wachsmann-Hogiu, D. L. Farkas, K. L. Black, E. Holler

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2 Citations (Scopus)

Abstract

Nanoconjugates of β-poly(L-malic acid) (PMLA) have been synthesized with modules active in drug delivery, drug release, blocking of tumor-affiliated mRNA by antisense oligonucleotides, penetration of blood and cellular barriers, tissue targeting, membrane permeation, fluorescence, and protection. PMLA of microbial origin is non-toxic, nonimmunogenic, biodegradable and highly suited as a scaffold for tailored nanoconjugate chemistry. The nanoconjugate of 550 kDa allowed fluorescence imaging of brain tumor and breast cancer implanted on mouse, targeted on the basis of tumor tissue-inherent enhanced permeability and retention (EPR) and antibody recognition. The nanoconjugates were designed to inhibit tumor growth by preventing angiogenesis.

Original languageEnglish (US)
Title of host publication2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings
Pages354-357
Number of pages4
Volume2
StatePublished - 2006
Event2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings - Boston, MA, United States
Duration: May 7 2006May 11 2006

Other

Other2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings
CountryUnited States
CityBoston, MA
Period5/7/065/11/06

Fingerprint

Nanoconjugates
Drug delivery
Tumors
Acids
Fluorescence
Tissue
Oligonucleotides
Antibodies
Scaffolds
Permeation
Brain
Blood
Membranes
Imaging techniques

Keywords

  • Antibodies
  • Antisense oligonucleotides
  • Fluorescence imaging
  • Tissue targeting
  • Tumor angiogenesis

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Ljubimova, J. Y., Fujita, M., Lee, B. S., Khazenzon, N. M., Wachsmann-Hogiu, S., Farkas, D. L., ... Holler, E. (2006). Nanoconjugates of poly(malic acid) with functional modules for drug delivery. In 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings (Vol. 2, pp. 354-357)

Nanoconjugates of poly(malic acid) with functional modules for drug delivery. / Ljubimova, J. Y.; Fujita, M.; Lee, B. S.; Khazenzon, N. M.; Wachsmann-Hogiu, Sebastian; Farkas, D. L.; Black, K. L.; Holler, E.

2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. Vol. 2 2006. p. 354-357.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Ljubimova, JY, Fujita, M, Lee, BS, Khazenzon, NM, Wachsmann-Hogiu, S, Farkas, DL, Black, KL & Holler, E 2006, Nanoconjugates of poly(malic acid) with functional modules for drug delivery. in 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. vol. 2, pp. 354-357, 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings, Boston, MA, United States, 5/7/06.
Ljubimova JY, Fujita M, Lee BS, Khazenzon NM, Wachsmann-Hogiu S, Farkas DL et al. Nanoconjugates of poly(malic acid) with functional modules for drug delivery. In 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. Vol. 2. 2006. p. 354-357
Ljubimova, J. Y. ; Fujita, M. ; Lee, B. S. ; Khazenzon, N. M. ; Wachsmann-Hogiu, Sebastian ; Farkas, D. L. ; Black, K. L. ; Holler, E. / Nanoconjugates of poly(malic acid) with functional modules for drug delivery. 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. Vol. 2 2006. pp. 354-357
@inproceedings{10032bf9fda04f6e9e35866db35d0964,
title = "Nanoconjugates of poly(malic acid) with functional modules for drug delivery",
abstract = "Nanoconjugates of β-poly(L-malic acid) (PMLA) have been synthesized with modules active in drug delivery, drug release, blocking of tumor-affiliated mRNA by antisense oligonucleotides, penetration of blood and cellular barriers, tissue targeting, membrane permeation, fluorescence, and protection. PMLA of microbial origin is non-toxic, nonimmunogenic, biodegradable and highly suited as a scaffold for tailored nanoconjugate chemistry. The nanoconjugate of 550 kDa allowed fluorescence imaging of brain tumor and breast cancer implanted on mouse, targeted on the basis of tumor tissue-inherent enhanced permeability and retention (EPR) and antibody recognition. The nanoconjugates were designed to inhibit tumor growth by preventing angiogenesis.",
keywords = "Antibodies, Antisense oligonucleotides, Fluorescence imaging, Tissue targeting, Tumor angiogenesis",
author = "Ljubimova, {J. Y.} and M. Fujita and Lee, {B. S.} and Khazenzon, {N. M.} and Sebastian Wachsmann-Hogiu and Farkas, {D. L.} and Black, {K. L.} and E. Holler",
year = "2006",
language = "English (US)",
isbn = "0976798573",
volume = "2",
pages = "354--357",
booktitle = "2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings",

}

TY - GEN

T1 - Nanoconjugates of poly(malic acid) with functional modules for drug delivery

AU - Ljubimova, J. Y.

AU - Fujita, M.

AU - Lee, B. S.

AU - Khazenzon, N. M.

AU - Wachsmann-Hogiu, Sebastian

AU - Farkas, D. L.

AU - Black, K. L.

AU - Holler, E.

PY - 2006

Y1 - 2006

N2 - Nanoconjugates of β-poly(L-malic acid) (PMLA) have been synthesized with modules active in drug delivery, drug release, blocking of tumor-affiliated mRNA by antisense oligonucleotides, penetration of blood and cellular barriers, tissue targeting, membrane permeation, fluorescence, and protection. PMLA of microbial origin is non-toxic, nonimmunogenic, biodegradable and highly suited as a scaffold for tailored nanoconjugate chemistry. The nanoconjugate of 550 kDa allowed fluorescence imaging of brain tumor and breast cancer implanted on mouse, targeted on the basis of tumor tissue-inherent enhanced permeability and retention (EPR) and antibody recognition. The nanoconjugates were designed to inhibit tumor growth by preventing angiogenesis.

AB - Nanoconjugates of β-poly(L-malic acid) (PMLA) have been synthesized with modules active in drug delivery, drug release, blocking of tumor-affiliated mRNA by antisense oligonucleotides, penetration of blood and cellular barriers, tissue targeting, membrane permeation, fluorescence, and protection. PMLA of microbial origin is non-toxic, nonimmunogenic, biodegradable and highly suited as a scaffold for tailored nanoconjugate chemistry. The nanoconjugate of 550 kDa allowed fluorescence imaging of brain tumor and breast cancer implanted on mouse, targeted on the basis of tumor tissue-inherent enhanced permeability and retention (EPR) and antibody recognition. The nanoconjugates were designed to inhibit tumor growth by preventing angiogenesis.

KW - Antibodies

KW - Antisense oligonucleotides

KW - Fluorescence imaging

KW - Tissue targeting

KW - Tumor angiogenesis

UR - http://www.scopus.com/inward/record.url?scp=33845210664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845210664&partnerID=8YFLogxK

M3 - Conference contribution

SN - 0976798573

SN - 9780976798576

VL - 2

SP - 354

EP - 357

BT - 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings

ER -